News Archive

Scientists and policy-makers have long argued that public investments in science have practical applications. Using data on patents linked to U.S. National Institutes of Health (NIH) grants over a 27-year period, we provide a large-scale accounting of linkages between public research investments and subsequent patenting. We find that about 10% of NIH grants generate a patent directly but 30% generate articles that are subsequently cited by patents. Although policy-makers often focus on direct patenting by academic scientists, the bulk of the effect of NIH research on patenting appears to be indirect. We also find no systematic relationship between the “basic” versus “applied” research focus of a grant and its propensity to be cited by a patent.

Doctors can rebuild parts of the body that have been damaged, but they need soft tissue to do it.

Whether it’s facial reconstruction after trauma, a masectomy as a result of breast cancer or something more cosmetic like stopping wrinkles, the person who needs the procedure is typically the one to provide the tissue.

When: Tuesday, April 11, 2017 from 5:30 PM to 7:30 PM EDT Add to Calendar

Where: Harbor Launch @ IMET 701 E Pratt St Baltimore, MD 21202

Let’s talk about the startup F word – Finance. It’s a critical component of a company’s success, and it’s more than just spreadsheets. We’re giving this topic its day in the sun, answering such questions as… When does a startup need a CFO? What functions should a CFO serve? What qualities are desirable in a CFO? How can startups without a CFO best attend to their finances?

Join us on Tuesday, April 11th from 5:30-7:30pm at the Columbus Center (701 E Pratt Street) for this fireside-chat style event, moderated by Ken Malone of BioHealth Innovation, Inc. and Early Charm Ventures. We will hear the experiences and perspectives of Eileen O’Rourke, Chief Financial Officer at The Abell Foundation, Steve Dubin, Principal, SDA Ventures LLC; Chairman, Enzymotec Ltd., and Ryan McQueeney, Chief Financial Officer at RedOwl.

Program: 6-7pm with BioBuzz networking before and after.

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) to manufacture and store bulk drug substance for its botulism antitoxin, BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)], valued at approximately $53 million with a five-year period of performance. This modification to the contract will enable future filling and deliveries of final drug product to the Strategic National Stockpile (SNS). BAT is indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients.

It’s a bit of a strange world when a company growing at perhaps 5% per year, with downside risks, trades at 23X TTM EPS (historical GAAP numbers), but that’s completely par for the course. The S&P 500 trades near 25X TTM EPS.

Some competitors to Roche Holding AG (OTCQX:RHHBY) trade much pricier than it does. Pfizer (NYSE:PFE) is at 29X. Before a one-time payment to settle a patent suit that affected Merck’s (NYSE:MRK) Q4 EPS, MRK was around 32X. Eli Lilly (NYSE:LLY), a smaller player, is at 33X.

The National Aeronautics and Space Administration will spend $87.5 million over the next five years to continue a research partnership with the University of Maryland, Baltimore County and University of Maryland, College Park and to bring on additional partners, the universities announced Thursday.

Scientists from the participating universities will study high energy astrophysics, gravitational waves, space exploration and planets in the solar system at NASA’s Goddard Space Flight Center in Greenbelt, said T. Jane Turner, a professor of physics who runs UMBC’s arm of the program.

The US-based University System of Maryland has set up a $25m fund called Maryland Momentum Fund to support startups formed within the system’s 12 public institutions.

Julie Lenzer, co-director of UM Ventures, a joint initiative of the University of Maryland, Baltimore and University of Maryland, said the university system had already committed $10m to the Maryland Momentum Fund.

Celebrate Your Organization’s Excellence in 2017!

Each year, UEDA members compete for our prestigious Awards of Excellence, which recognize outstanding, leading-edge higher education projects and initiatives promoting economic development and engagement. Never content to rest on our laurels, however, last year saw a significant revamping of the Awards program to reflect UEDA’s ongoing research on economic development and engagement in higher education. We hope you will join us!

Four weeks into my first semester of college, my academic confidence was completely shredded. I had back-to-back tests in cell biology, chemistry, and calculus, and my time management skills weren’t quite there yet. I failed my calculus exam, and suddenly I wasn’t sure I had the intelligence or the ability to get a degree in science.

A group focused on spurring regional cooperation to boost the economy wants to raise $3 million to $5 million to rebrand Greater Washington and challenge its reputation as an epicenter of politics and gridlock.

The 2030 Group, a consortium of businesses, organizations and executives, will unveil a new video and website Thursday that will serve as a sort of platform for future marketing efforts. Then a call to fund the regionwide branding effort will begin.